ClinicalTrials.gg
CompletedNCT05574556Updated Oct 10, 2022

Electromiographic Analysis of the Quadriceps After Trauma

An observational study in Leg Injury and Bone Fracture, sponsored by Faculdade de Ciências Médicas da Santa Casa de São Paulo. Completed at 1 site in Brazil. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2022-10-10.

Sponsored by Faculdade de Ciências Médicas da Santa Casa de São Paulo · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
74
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The lower limb is the region most affected by fractures in the human body. The magnitude of the trauma can cause injuries to structures adjacent to the fracture, promoting joint instability and consequently predisposition to osteoarthritis. The treatment of fractures can be performed conservatively or surgically, and one of the consequences of the surgery is arthrogenic muscle inhibition, which presents itself as a marked muscle weakness due to inhibition of the central nervous system that prevents adequate muscle activation. However, recruiting the quadriceps is the most commonly used goal to determine the patient's return to activities. Physiotherapy has several resources for the functional activation of the quadriceps muscle, such as neuromuscular electrostimulation (NMES), verbal command of muscle activation and neuromatrix techniques. Thus, the objective of this study will be to analyze, by means of electromyography, the myoelectric activity of the quadriceps muscle in individuals undergoing physical therapy intervention, affected by some fracture of the lower limb.

02

Conditions studied

  • Leg Injury
  • Bone Fracture
03

In context

Leg Injuries

65 studies on the registry are indexed under Leg Injuries; 12 are open to participants now.

This study's enrollment of 74 is below the median of 200 across 17 observational studies indexed under Leg Injuries.

Browse Leg Injuries studies →

Lead sponsor

Faculdade de Ciências Médicas da Santa Casa de São Paulo is the lead sponsor of 41 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

ANALYSIS OF THE QUADRICEPS AFTER TRAUMA IN LOWER MEMBERSINTERVENTION

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • trauma in lower member intervention

Exclusion criteria

Exclusion Criteria:

  • neuromuscular disease
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
74 participants (actual)
Patient registry
No

Groups and cohorts

  • myoelectric activity of the quadriceps muscle

    electromyography myoelectric activity of the quadriceps muscle

06

What researchers measure

Primary outcomes

  1. electromyography

    will be performed an examination of electrical muscle conductance

    Time frame: one time - during the procedure

Secondary outcomes

  1. myoelectric activity of the quadriceps muscle

    will be performed an examination of electrical muscle conductance

    Time frame: one time - during the procedure

07

Study locations

1 site
  • Claudio Cazarini Júnior
    Sao Paulo, São Paulo 03156001, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05574556
Lead sponsor
Faculdade de Ciências Médicas da Santa Casa de São Paulo
Responsible party
Sponsor
First posted
Oct 10, 2022
Start date
Jan 10, 2021
Primary completion
Apr 10, 2021
Completion
Apr 10, 2022
Last update
Oct 10, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion